PARK7 antibody

Ref. 3D-10R-8372

Produktinformation

• Name: PARK7 antibody

Beschreibung

The PARK7 antibody is a highly specialized monoclonal antibody that targets and inhibits the activity of phosphatase enzymes. This antibody has been extensively studied for its potential therapeutic applications in various fields, including insulin signaling, collagen synthesis, chemokine regulation, nuclear processes, and growth factor signaling.

In laboratory studies, the PARK7 antibody has shown promising results in modulating insulin levels and improving insulin sensitivity. It has also been found to enhance collagen production and promote tissue repair. Additionally, this antibody has demonstrated an ability to regulate chemokine expression, which plays a crucial role in immune response and inflammation.

Furthermore, research suggests that the PARK7 antibody may have neurotrophic effects on neuronal cells, making it a potential candidate for the treatment of neurodegenerative disorders. Studies have also explored its role in liver metabolism and its interaction with ketamine and other drugs metabolized by liver microsomes.

Overall, the PARK7 antibody represents an exciting avenue of research in the field of Life Sciences

• Marke: Biosynth